More issues

How to Get Natpara Covered by Blue Cross Blue Shield in North Carolina: Complete Appeals Guide with Forms and Deadlines

Answer Box: Getting Natpara Covered by Blue Cross Blue Shield in North Carolina Important Update: Natpara manufacturing ended December 2024, with the Special Use Program ceasing December 31, 2025. New patient requests are typically denied due to discontinued availability. For existing patients transitioning off Natpara, focus on documenting medical necessity
6 min read

How to Get Mycapssa (Octreotide Oral) Covered by Cigna in Texas: PA Forms, Appeals & Success Tips

Answer Box: Getting Mycapssa Covered by Cigna in Texas Mycapssa (oral octreotide) requires prior authorization from Cigna with specific documentation: acromegaly diagnosis, prior response to injectable octreotide/lanreotide for 3+ months, and endocrinologist prescription. Fastest path: Have your endocrinologist submit PA with baseline IGF-1 labs, treatment history, and medical necessity
5 min read

Xospata (Gilteritinib) Approval with UnitedHealthcare in Virginia: Answers to the Most Common Questions

Answer Box: Getting Xospata Covered by UnitedHealthcare in Virginia Xospata (gilteritinib) requires prior authorization from UnitedHealthcare for relapsed/refractory AML with confirmed FLT3 mutations. Fastest approval path: Submit PA with FDA-approved FLT3 test results, prior therapy documentation, and oncologist's medical necessity letter. First step today: Have your hematologist/
5 min read

How to Get Elaprase (Idursulfase) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Elaprase (Idursulfase) Covered by Cigna in North Carolina Eligibility: Cigna covers Elaprase for Hunter syndrome (MPS II) when you have confirmed enzymatic deficiency AND genetic testing showing IDS gene mutations. Fastest approval path: Submit prior authorization with both biochemical and molecular diagnostic proof, weight-based dosing calculations, and
6 min read